Palvella Therapeutics, Inc.
PVLA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001583648
In the last 90 days, Palvella Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 196 institutions reported holding it in 13F filings for Q2 2026, worth $2.15B in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Palvella Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- +8 vs. Q4 2024
- Shares held
- 5.12M
- +1.09M (+27.0%) vs. Q4 2024
- Total value
- $143.4M
- +$95.0M (+196.2%) vs. Q4 2024
- New holders
- 15
- 9 more added
- Sold out
- 7
- 4 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PVLA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 196 | $2.15B |
| Q1 2026 | 180 | $1.64B |
| Q4 2025 | 140 | $1.02B |
| Q3 2025 | 100 | $534.5M |
| Q2 2025 | 67 | $133.2M |
| Q1 2025 | 41 | $143.4M |
| Q4 2024 | 33 | $48.4M |
| Q3 2024 | 25 | $10.1M |
| Q2 2024 | 20 | $3.57M |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Palvella Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Suvretta Capital Management, LLC | 714,463 | $20.0M | 0.81% | 00.0% | Unchanged |
| BVF Inc | 696,555 | $19.5M | 0.79% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 690,012 | $19.3M | 0.88% | +36,120+5.5% | Added |
| Samsara BioCapital, LLC | 679,486 | $19.0M | 3.39% | 00.0% | Unchanged |
| Adams Street Partners LLC | 409,666 | $11.5M | 10.15% | 00.0% | Unchanged |
| Millennium Management LLC | 269,837 | $7.55M | 0.01% | +269,837 | New |
| Nantahala Capital Management, LLC | 250,062 | $7.00M | 0.58% | 00.0% | Unchanged |
| Woodline Partners LP | 194,167 | $5.43M | 0.04% | +194,167 | New |
| Opaleye Management Inc. | 172,357 | $4.82M | 1.07% | +172,357 | New |
| Blue Owl Capital Holdings LP | 140,259 | $3.93M | 1.27% | −109,803−43.9% | Reduced |
| Vanguard Group Inc | 138,433 | $3.87M | 0.00% | +127,091+1,120.5% | Added |
| Susquehanna International Group, LLP | 114,388 | $3.20M | 0.01% | +114,388 | New |
| BlackRock, Inc. | 110,758 | $3.10M | 0.00% | +97,820+756.1% | Added |
| Geode Capital Management, LLC | 94,199 | $2.64M | 0.00% | +79,929+560.1% | Added |
| Royce & Associates LP | 71,514 | $2.00M | 0.02% | +71,514 | New |
| AWM Investment Company, Inc. | 69,416 | $1.94M | 0.27% | +69,416 | New |
| UBS Oconnor LLC | 48,664 | $1.36M | 0.03% | +48,664 | New |
| DAFNA Capital Management LLC | 43,348 | $1.21M | 0.34% | −28,104−39.3% | Reduced |
| Marshall Wace, LLP | 30,345 | $849.4K | 0.00% | +30,345 | New |
| Strid Group, LLC | 29,219 | $817.8K | 0.13% | +29,219 | New |
| Cresset Asset Management, LLC | 20,911 | $585.3K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 19,053 | $533.3K | 0.00% | +19,053 | New |
| Toronto Dominion Bank | 18,872 | $528.2K | 0.00% | +5,661+42.9% | Added |
| Northern Trust Corp | 16,635 | $465.6K | 0.00% | +16,635 | New |
| Renaissance Technologies LLC | 15,258 | $427.1K | 0.00% | −6,113−28.6% | Reduced |
| Deltec Asset Management LLC | 12,500 | $349.9K | 0.08% | 00.0% | Unchanged |
| State Street Corp | 12,062 | $337.6K | 0.00% | +12,062 | New |
| UBS Group AG | 10,054 | $281.4K | 0.00% | +9,852+4,877.2% | Added |
| Morgan Stanley | 9,907 | $277.3K | 0.00% | +9,816+10,786.8% | Added |
| Balyasny Asset Management LLC | 8,176 | $228.8K | 0.00% | +8,176 | New |
| Bank of America Corp | 7,609 | $213.0K | 0.00% | +7,597+63,308.3% | Added |
| Spire Wealth Management | 2,516 | $70.4K | 0.00% | +2,516 | New |
| Citigroup Inc | 2,246 | $62.9K | 0.00% | +1,138+102.7% | Added |
| Group One Trading, L.P. | 312 | $8.73K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 63 | $1.76K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 50 | $1.40K | 0.00% | 00.0% | Unchanged |
| Truvestments Capital LLC | 14 | $392 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 5 | $128 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 3 | $84 | 0.00% | −23−88.5% | Reduced |
| Jones Financial Companies LLLP | 3 | $84 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 2 | $0 | 0.00% | +2 | New |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −144,641−100.0% | Sold out |
| BML Capital Management, LLC | 0 | $0 | 0.00% | −42,130−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −10,408−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −1,549−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −175−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −138−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −7−100.0% | Sold out |